#IDtwitter #Immunology A Detailed Overview of #SARSCoV2 #Omicron: Its Sub-variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies 🧵
📌mdpi-res.com/d_attachment/v… @VirusesMDPI
📌 sciencedirect.com/science/articl…
📌mdpi-res.com/d_attachment/v… @VirusesMDPI
📌 sciencedirect.com/science/articl…
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
nejm.org/doi/full/10.10… @NEJM
nejm.org/doi/full/10.10… @NEJM
Characterization of #SARSCoV2 recombinants and emerging Omicron sublineages
📌 ncbi.nlm.nih.gov/pmc/articles/P…
📌 medrxiv.org/content/10.110…
📌 biorxiv.org/content/10.110…
📌 ncbi.nlm.nih.gov/pmc/articles/P…
📌 medrxiv.org/content/10.110…
📌 biorxiv.org/content/10.110…
#hybridimmunity following infection with Omicron BA.1 or BA.2 when compared with vaccine-only immunity leads to substantially increased protection against BA.5 reinfection for up to 8 months.
thelancet.com/journals/lanin…
thelancet.com/journals/lanin…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
